Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bernstein Litowitz Berger & Grossmann (BLB&G) is a prominent international law firm specializing in securities fraud, corporate governance, and shareholder rights litigation. While not a biotechnology or pharmaceutical company, the firm is highly active in the life sciences sector, frequently representing institutional investors in class-action lawsuits against healthcare companies regarding misleading clinical trial data and regulatory disclosures. BLB&G is widely recognized for recovering billions of dollars for investors and is often ranked as a top-tier firm for plaintiffs' litigation. The firm provides legal counsel to many of the world's largest pension funds and institutional asset managers from its offices across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bernstein Litowitz Berger & Grossmann.